Skip to main content

Table 4 The comparison of the mortality between RR/MDR-TBM and NRR/MDR-TBM groups

From: Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China

 

Total

RR/MDR-TMB

nRR/MDR-TBM

P value

Deaths

24

3

21

 

Survivors

63

9

54

 

Loss to follow-up

50

0

50

 

Mortality1

27.6%

25.0%

28.0%

0.895

Mortality2

17.5%

25.0%

16.8%

0.752

Mortality3

54.0%

25.0%

56.8%

0.071

  1. Mortality 1: excluding those lost to follow-up. Mortality 2: including those lost to follow-up and assuming all of them survived. Mortality 3: including those lost to follow-up and assuming all of them demised
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us